(S)-2-{2-[((S)-2-{2-[3-(4-Cyano-benzyl)-3H-imidazol-4-yl]-acetylamino}-3-methyl-pentyl)-naphthalen-1-ylmethyl-amino]-acetylamino}-4-methylsulfanyl-butyramide

InChIKey	`ROFGUUIGELBBOO-QTSVPKBSSA-N`
Compound Name	(S)-2-{2-[((S)-2-{2-[3-(4-Cyano-benzyl)-3H-imidazol-4-yl]-acetylamino}-3-methyl-pentyl)-naphthalen-1-ylmethyl-amino]-acetylamino}-4-methylsulfanyl-butyramide
Canonical SMILES	`CCC(C)[C@@H](CN(CC(=O)N[C@@H](CCSC)C(N)=O)Cc1cccc2ccccc12)NC(=O)Cc1cncn1Cc1ccc(C#N)cc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	7.89
Source	ChEMBL;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P49354	FNTA	Homo sapiens	Human	PF01239	7.9	pIC50	TTD_MultiTarget
P49356	FNTB	Homo sapiens	Human	PF00432	7.9	IC50	ChEMBL